Stock Taper 
FEED
$1.03
▲ UP 0.00% (0.00)
KEY STATISTICS
Market Cap$797.96 K
52w High$5.98
52w Low$0.29
Dividend Yield—
Frequency—
P/E-0.01
Volume1.13M
Shares Out.1.09M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Doron Robert Besser
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 12, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
13
PRICE TARGET
Target High$4.65
Target Low$4.65
Target Median$4.65
Target Consensus$4.65
UPCOMING EARNINGS
DateNov 17, 2026
DayTuesday
Rev. Est.—
NOV
17
TUE
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-09-01 | Reverse | 1:12 |
| 2025-08-12 | Reverse | 1:10 |
| 2025-03-14 | Reverse | 1:11 |
| 2023-02-09 | Reverse | 1:20 |
PRICE
$1.03 ▲ UP 0.00% (+$0.00)About ENvue Medical, Inc.
https://envuemed.com ↗NanoVibronix, Inc. develops noninvasive biological response-activating devices like UroShield and PainShield, serving markets in the U.S., Europe, Australia, India, and Israel since 2003, headquartered in Tyler, TX.
INDUSTRY
Medical - Specialties
A PRODUCT ENVUE MEDICAL, INC. IS KNOWN FOR
Over-the-Counter Reusable ENFit Syringes
ENvue Medical's reusable OTC syringes for enteral feeding and medication delivery target clinical and home care, reflecting their strategic focus on the enteral care market and ongoing commercialization via new distribution partnerships.
ETFS HOLDING THIS STOCK
ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score2
INSIDER TRADES
★
OTHER: NO LONGER A 10% HOLDER
Glibert Christian Michael
Purchase · —
2026-04-15
★
OFFICER
Fernandez-McGovern Nicole M.
— · —
2025-12-18
★
10 PERCENT OWNER
Glibert Christian Michael
Purchase · 240.0K shares
2026-01-14
★
10 PERCENT OWNER
Glibert Christian Michael
— · —
2026-01-14